Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Uterine leiomyoma: available medical treatments and new possible therapeutic options.

Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, Castellucci M, Ciarmela P.

J Clin Endocrinol Metab. 2013 Mar;98(3):921-34. doi: 10.1210/jc.2012-3237. Epub 2013 Feb 7. Review.

PMID:
23393173
2.

Role of Medical Management for Uterine Leiomyomas.

Kashani BN, Centini G, Morelli SS, Weiss G, Petraglia F.

Best Pract Res Clin Obstet Gynaecol. 2016 Jul;34:85-103. doi: 10.1016/j.bpobgyn.2015.11.016. Epub 2015 Nov 25. Review.

PMID:
26796059
3.

Medical management of fibroids.

Sankaran S, Manyonda IT.

Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):655-76. doi: 10.1016/j.bpobgyn.2008.03.001. Epub 2008 May 12. Review.

PMID:
18468953
4.

Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.

Lethaby A, Vollenhoven B, Sowter M.

Cochrane Database Syst Rev. 2001;(2):CD000547. Review.

PMID:
11405968
5.
6.
7.

Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.

Lethaby A, Vollenhoven B, Sowter M.

Cochrane Database Syst Rev. 2000;(2):CD000547. Review. Update in: Cochrane Database Syst Rev. 2001;(2):CD000547.

PMID:
10796723
8.

Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids.

Talaulikar VS, Manyonda IT.

Adv Ther. 2012 Aug;29(8):655-63. doi: 10.1007/s12325-012-0042-8. Epub 2012 Aug 16. Review.

PMID:
22903240
9.

Contemporary management of uterine fibroids: focus on emerging medical treatments.

Singh SS, Belland L.

Curr Med Res Opin. 2015 Jan;31(1):1-12. doi: 10.1185/03007995.2014.982246. Epub 2014 Nov 12. Review. Erratum in: Curr Med Res Opin. 2016;32(4):797.

PMID:
25365466
10.

Selective progesterone receptor modulators: an update.

Benagiano G, Bastianelli C, Farris M, Brosens I.

Expert Opin Pharmacother. 2014 Jul;15(10):1403-15. doi: 10.1517/14656566.2014.914494. Epub 2014 Apr 30. Review.

PMID:
24787486
11.

Bleeding associated with uterine leiomyomas. Tailor treatment to the individual patient.

[No authors listed]

Prescrire Int. 2014 May;23(149):130-5. Review.

PMID:
24926520
12.

An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.

Bartels CB, Cayton KC, Chuong FS, Holthouser K, Arian SE, Abraham T, Segars JH.

Clin Obstet Gynecol. 2016 Mar;59(1):30-52. doi: 10.1097/GRF.0000000000000171. Review.

PMID:
26756261
13.

Fibroid growth and medical options for treatment.

Chabbert-Buffet N, Esber N, Bouchard P.

Fertil Steril. 2014 Sep;102(3):630-9. doi: 10.1016/j.fertnstert.2014.07.1238. Review.

PMID:
25171950
14.

Options for medical treatment of myomas.

Rackow BW, Arici A.

Obstet Gynecol Clin North Am. 2006 Mar;33(1):97-113. Review.

PMID:
16504809
15.

A benefit-risk assessment of medical treatment for uterine leiomyomas.

De Leo V, Morgante G, La Marca A, Musacchio MC, Sorace M, Cavicchioli C, Petraglia F.

Drug Saf. 2002;25(11):759-79. Review.

PMID:
12222988
16.

Progestin-releasing intrauterine systems and leiomyoma.

Kaunitz AM.

Contraception. 2007 Jun;75(6 Suppl):S130-3. Epub 2007 Mar 9. Review.

PMID:
17531604
17.

Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review.

Jiang W, Shen Q, Chen M, Wang Y, Zhou Q, Zhu X, Zhu X.

Steroids. 2014 Aug;86:69-78. doi: 10.1016/j.steroids.2014.05.002. Epub 2014 May 14. Review.

PMID:
24832215
18.

[Hormonal treatments for hemorrhaging secondary to fibroids. An alternative or complement to surgery?].

Cancelo Hidalgo MJ.

Med Clin (Barc). 2013 Jul;141 Suppl 1:30-4. doi: 10.1016/S0025-7753(13)70050-2. Review. Spanish.

PMID:
24314565
19.

Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.

Talaulikar VS, Manyonda I.

Eur J Obstet Gynecol Reprod Biol. 2012 Dec;165(2):135-40. doi: 10.1016/j.ejogrb.2012.07.023. Epub 2012 Aug 15. Review.

PMID:
22901974
20.

Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.

Lethaby AE, Cooke I, Rees M.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD002126.

PMID:
16235297

Supplemental Content

Support Center